Rohto Pharmaceutical Market Cap

Rohto Pharmaceutical has a market cap or net worth of 551.01 billion as of April 16, 2026. Its market cap has increased by 9.62% in one year.

Market Cap

551.01B

Enterprise Value

546.11B

Revenue

335.80B

Ranking

n/a

PE Ratio

16.41

Stock Price

2,438.50

Market Cap Chart

Since July 4, 1997, Rohto Pharmaceutical's market cap has increased from 64.95B to 551.01B, an increase of 748.41%. That is a compound annual growth rate of 7.71%.

Market Cap History

Date	Market Cap	% Change
Apr 15, 2026	550.56B	-7.29%
Dec 30, 2025	593.83B	-9.54%
Dec 30, 2024	656.47B	1.21%
Dec 29, 2023	648.60B	22.54%
Dec 30, 2022	529.28B	33.52%
Dec 30, 2021	396.39B	13.75%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Unicharm	1.64T
Shiseido Company	1.28T
Lion Corporation	442.78B
Kobayashi Pharmaceutical	440.01B
KOSE Holdings	327.87B
Pola Orbis Holdings	290.88B
Paltac	286.58B
MTG Co., Ltd.	247.78B

Market Cap Rankings